MBRX
MBRX: KLEMP WALTER V discloses securities transactions
KLEMP WALTER V reported Exercise or conversion in Moleculin Biotech, Inc.: 57 units of Common Stock, dated 2026-11-04. The full Form 4 contains 3 transaction entries.
LoadingLoadingLoadingMBRX
KLEMP WALTER V reported Exercise or conversion in Moleculin Biotech, Inc.: 57 units of Common Stock, dated 2026-11-04. The full Form 4 contains 3 transaction entries.
MBRX
Foster Jonathan P. reported Exercise or conversion in Moleculin Biotech, Inc.: 41 units of Common Stock, dated 2026-11-04. The full Form 4 contains 3 transaction entries.
MBRX
PICKER DONALD H reported Exercise or conversion in Moleculin Biotech, Inc.: 17 units of Common Stock, dated 2026-11-04. The full Form 4 contains 3 transaction entries.
AGYS
Abdelrahman Joe Ahmed Youssef reported Grant or award in AGILYSYS INC: 2789 units of Restricted Stock Units (derivative), dated 2026-11-04. The full Form 4 contains 1 transaction entry.
EDIT
O'Neill Gilmore Neil reported 43,567 shares of Common Stock in Editas Medicine, Inc. as grants or awards dated 2026-11-05. The Form 4 was disclosed on Nov 6, 2026. These were stock awards, not open-market purchases.
GVA
WOOLSEY STACI M reported Tax/exercise withholding in GRANITE CONSTRUCTION INC: 188 units of Common Stock, dated 2026-11-05. The full Form 4 contains 1 transaction entry.
EDIT
Burkly Linda reported 16,533 shares of Common Stock in Editas Medicine, Inc. as grants or awards dated 2026-11-05. The Form 4 was disclosed on Nov 6, 2026. These were stock awards, not open-market purchases.
MDGL
Kelley Shannon T reported Sale in MADRIGAL PHARMACEUTICALS, INC.: 1077 units of Common Stock, dated 2026-11-06. The full Form 4 contains 1 transaction entry.
GNRC
Taffe Norman P reported Sale in GENERAC HOLDINGS INC.: 200 units of Common Stock, dated 2026-11-05. The full Form 4 contains 2 transaction entries.
ORLY
SASTRE MARIA reported Sale in O REILLY AUTOMOTIVE INC: 1200 units of Common stock, dated 2026-11-04. The full Form 4 contains 1 transaction entry.
LEVI
Gowans Jason reported Sale in LEVI STRAUSS & CO: 3494 units of Class A Common Stock, dated 2026-11-04. The full Form 4 contains 1 transaction entry.
W
Tan Fiona reported Sale in Wayfair Inc.: 8000 units of Class A Common Stock, dated 2026-11-04. The full Form 4 contains 2 transaction entries.
VRRM
Conti Craig C reported Sale in VERRA MOBILITY Corp: 7321 units of Class A Common Stock, dated 2026-11-04. The full Form 4 contains 1 transaction entry.
YOU
Alclear Investments, LLC reported Sale in Clear Secure, Inc.: 165395 units of Class A Common Stock, dated 2026-11-04. The full Form 4 contains 5 transaction entries.
BWB
Urness Todd B. reported Gift in Bridgewater Bancshares Inc: 4187 units of Common Stock, dated 2026-11-04. The full Form 4 contains 2 transaction entries.
CVS
Shah Prem S reported Purchase in CVS HEALTH Corp: 23855 units of Common Stock, dated 2026-11-06. The full Form 4 contains 1 transaction entry.
AZO
JACKSON JAMERE reported Exercise or conversion in AUTOZONE INC: 6900.0000 units of Common Stock, dated 2026-11-04. The full Form 4 contains 21 transaction entries.
CBOE
Tomczyk Fredric J reported Gift in Cboe Global Markets, Inc.: 500 units of Common Stock, dated 2026-11-04. The full Form 4 contains 2 transaction entries.
ALGT
Pollard Charles W. reported Sale in Allegiant Travel CO: 10000 units of Common Stock, dated 2026-11-06. The full Form 4 contains 1 transaction entry.
SUNS
Hetzel Brandon reported Other (see filing) in Sunrise Realty Trust, Inc.: 14134 units of Common Stock, dated 2026-11-05. The full Form 4 contains 1 transaction entry.
CPSS
BRADLEY CHARLES E JR reported Sale in CONSUMER PORTFOLIO SERVICES, INC.: 200000 units of Common Stock, no par value, dated 2026-11-04. The full Form 4 contains 1 transaction entry.
HLF
Schaefer Scott Stephen reported Grant or award in HERBALIFE LTD.: 3391 units of Stock Appreciation Rights (derivative), dated 2026-11-04. The full Form 4 contains 1 transaction entry.
SVIA
Noor Shain reported 502,513 shares of Common Stock, par value $0.001 per share in Silvia, Inc. as grants or awards dated 2026-05-19. The Form 4 was disclosed on Nov 6, 2026. These were stock awards, not open-market purchases.
HLF
DeSimone John reported Grant or award in HERBALIFE LTD.: 34593 units of Stock Appreciation Rights (derivative), dated 2026-11-04. The full Form 4 contains 1 transaction entry.
